Lv4
710 积分 2021-06-15 加入
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
8小时前
待确认
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing
15天前
已完结
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
3个月前
已完结
Y Chromosome of Aisin Gioro, the Imperial House of Qing Dynasty
6个月前
已完结
[Guidelines for the diagnosis and management of multiple myeloma in China (2024 revision)]
8个月前
已完结
皖公网安备34019202002308
